While current patch technology does not match injection efficacy, improvements may create viable alternatives
Patients already on compounded semaglutide who want to consolidate their supplementation
*Patients without diabetes and with BMI 30, or BMI 27 plus a weight-related condition, lost an average of 15% of their body weight in 1 year, when paired with healthy lifestyle changes (compared to 2.4% with diet and exercise alone)
Positioned as a maximum-tier therapeutic intervention, Sematrinity 4mg is tailored specifically for individuals who have built solid biological tolerance to introductory strengths and require a maximum strength baseline to completely conquer stubborn fat-loss plateaus, silence intense food noise, and maintain excellent glycemic control
Book your consultation at Better Med Spa and experience where beauty meets expert care tailored to your individualized goals
18F-radiolabeled analogs of exendin-4 for PET imaging of GLP-1 in insulinoma